Search

Your search keyword '"epstein—barr virus"' showing total 1,401 results

Search Constraints

Start Over You searched for: Descriptor "epstein—barr virus" Remove constraint Descriptor: "epstein—barr virus" Publication Type News Remove constraint Publication Type: News
1,401 results on '"epstein—barr virus"'

Search Results

1. Updated Results of Phase 3 ALLELE Study Presented at 66th American Society of Hematology Annual Meeting Confirm Efficacy, Safety and Durability of Novel Allogeneic Cell Therapy Tabelecleucel in Relapsed or Refractory Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)

3. Metro North Hospital and Health Service Researchers Update Understanding of Epstein-Barr Virus (Autologous Epstein-Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis)

4. New Epstein-Barr Virus Study Findings Recently Were Published by Researchers at Lausanne University Hospital and University of Lausanne (EBNA-1 and VCA-p18 immunoglobulin markers link Epstein-Barr virus immune response and brain's myelin ...)

8. Findings from City of Hope National Medical Center Has Provided New Data on Epstein-Barr Virus (Epstein-barr Virus-positive, Primary Cutaneous Marginal Zone Lymphoma, With Transformation: Case Report and Review of the Literature)

9. University of Science and Technology of China Researchers Advance Knowledge in Epstein-Barr Virus (Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics ...)

10. Researchers at Affiliated Hospital of Southwest Jiaotong University Zero in on Epstein-Barr Virus (Molecular characteristics of 14 239 patients with microsatellite instability colorectal cancer)

11. Researchers at Nagano Red Cross Hospital Release New Data on Herpes Zoster Virus (Successful Treatment of Epstein-barr Virus Reactivation-associated Transverse Myelitis Following Herpes Zoster With Intravenous Rituximab In a Cord Blood ...)

12. State Key Laboratory of Oncology in South China Researchers Describe Research in Epstein-Barr Virus (Detection of Epstein-Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, ...)

13. Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome

14. Pierre Fabre Pharmaceuticals Inc. announces the FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel(r)) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

15. Pierre Fabre Pharmaceuticals Inc. announces the FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

16. Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

18. GUATEMALAN INSTITUTE OF SOCIAL SECURITY -IGSS- invites tenders for P-208/202 C-12753; Epstein Barr Virus Antibodies Igm, (Mononucleosis) Reagent for Determination Of, Test

19. MONTEBELLO DIAGNOSTICS AS secures contract for Laboratory, optical and precision equipments (excl glasses) – Reagents for quantitative determination of cytomeg virus (CMV) DNA and Epstein-Barr virus (EBV) DNA for delivery to Helse Bergen HF

20. Researchers at University of Simon Bolivar Release New Data on Epstein-Barr Virus (Gene profiling of Epstein-Barr Virus and human endogenous retrovirus in peripheral blood mononuclear cells of SLE patients: immune response implications)

21. University of Pavia Researcher Discusses Research in Epstein-Barr Virus [Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review]

22. Study Data from Baylor University College of Medicine Provide New Insights into Epstein-Barr Virus (Rejection Resistant Cd30.car-modified Epstein-barr Virus-specific T Cells As an Off-the-shelf Platform for Cd30+lymphoma)

23. Researchers at University Hospital of Split Zero in on Epstein-Barr Virus (The Abundance of FOXP3, FOXP3/CD4 and CD8 Cells in the Microenvironment of Nodular Sclerosis and Mixed Cellularity Subtypes Is Associated with the Epstein-Barr Virus ...)

24. New Epstein-Barr Virus Study Findings Have Been Published by Researchers at Capital Medical University (Enhancing diagnostic precision in EBV-related HLH: a multifaceted approach using 18F-FDG PET/CT and nomogram integration)

25. Sri Jayadeva Institute of Cardiovascular Sciences and Research Researchers Target Epstein-Barr Virus (Left ventricular apical aneurysm in Takayasu arteritis and chronic active Epstein-Barr virus infection)

27. Study Findings from University Health Network Broaden Understanding of Personalized Medicine (Adult-Onset Systemic Chronic Active Epstein-Barr Virus Disease: A Case Report Highlighting Unique Immunophenotype and Novel Molecular Insights in the ...)

29. Study Results from Helix Biogen Institute Provide New Insights into Epstein-Barr Virus (Exploring the nuclear proteins, viral capsid protein, and early antigen protein using immunoinformatic and molecular modeling approaches to design a vaccine ...)

31. Studies from Medical University in the Area of Epstein-Barr Virus Described (Generalized lymphadenopathy in the presence of acute Epstein-Barr virus infection as the initial manifestation of systemic lupus erythematous: A case report)

32. Pierre Fabre Pharmaceuticals Inc. announces the FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel Tab-cel® for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

34. Researcher at Tehran University of Medical Sciences Zeroes in on Epstein-Barr Virus (Identification of New Putative MicroRNAs in Epstein-barr Virus Genome for Medical and Biotechnological Applications)

37. Fred Hutchinson Cancer Research Center Researchers Add New Findings in the Area of Epstein-Barr Virus (A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challenge)

38. New Epstein-Barr Virus Findings Reported from Umea University (Interactions Between High Seroreactivity To Human Herpes Virus 6a and Epstein-barr Virus In Ms Development: a Presymptomatic Case-control Study)

39. Sun Yat-sen University Cancer Center Researchers Advance Knowledge in Epstein-Barr Virus (A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection)

40. Patent Issued for Epstein-Barr virus antibodies and uses thereof (USPTO 12012446)

41. Researcher at Center for Cancer Research Has Published New Study Findings on HIV/AIDS (HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus)

42. Patent Issued for Epstein-barr virus vaccines (USPTO 12005115)

43. Technical University Munich (TU Munich) Researchers Advance Knowledge in Epstein-Barr Virus (Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious ...)

44. Scientists Uncover Links Between MS and Epstein-Barr Virus

46. SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford

47. Atara Biotherapeutics Submits Tabelecleucel Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA

48. Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA

49. Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Catalog

Books, media, physical & digital resources